Opinion

Video

Limitations of Conventional Imaging for Assessing Renal Masses

Experts on kidney cancer review challenges associated with limitations of conventional imaging for assessing renal masses and how to potentially improve sensitivity and specificity.

Related Videos
2 experts are featured in this series.
2 experts are featured in this series.
Rebecca A. Campbell, MD, answers a question during a Zoom video interview
1 expert in this video
1 expert in this video
1 expert is featured in this series.
1 expert is featured in this series.
Related Content
Skyler Howell, MD | Credit: X.com
April 28th 2025

AUA 2025: GLP-1 RAs could improve sperm count in overweight men

Patrick Campbell
New research reveals GLP-1 receptor agonists may enhance sperm counts in overweight men.
Pearls & Perspectives: Expanding BPH care & patient choice, with Kevin Zorn, MD, at AUA 25
May 4th 2025

Pearls & Perspectives: Expanding BPH care & patient choice, with Kevin Zorn, MD, at AUA 25

Amy M. Pearlman, MD Kevin C. Zorn, MD, FRCSC, FACS
Urologists discuss innovative BPH treatments, emphasizing personalized care, and the importance of ejaculatory preservation.
Pablo Suarez, MS-4 | Credit: UCSF
April 26th 2025

Drinking water contaminants could increase risk of kidney stones, study finds

Patrick Campbell
New research links higher drinking water contaminants to increased kidney stone risk.
Pearls & Perspectives: Evolving role of APPs in urology, with Corinna Hughes, DNP, at AUA 2025
May 1st 2025

Pearls & Perspectives: Evolving role of APPs in urology, with Corinna Hughes, DNP, at AUA 2025

Amy M. Pearlman, MD
Corinna Hughes, DNP, sits down with Amy Pearlman, MD, to discuss the evolving recognition of APPs in urology.
Stacy Loeb, MD, MSc, PhD | Credit: NYU Langone Health
April 26th 2025

TikTok, social media does more harm than good for prostate cancer education

Patrick Campbell
Social media spreads significant misinformation about prostate cancer. Experts urge clinicians to provide trusted information sources.
Perioperative lenvatinib/pembrolizumab shows promise in non-metastatic ccRCC
April 3rd 2025

Perioperative lenvatinib/pembrolizumab shows promise in non-metastatic ccRCC

Mehmet Asim Bilen, MD Hannah Clarke
"The combination demonstrated clinical activity and an acceptable safety profile in the perioperative setting for locally advanced, non-metastatic clear cell RCC," says Mehmet Asim Bilen, MD.
© 2025 MJH Life Sciences

All rights reserved.